"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
No specific antidote for IFEX (ifosfamide) is known. Management of overdosage would include general supportive measures to sustain the patient through any period of toxicity that might occur.
Continued use of IFEX (ifosfamide) is contraindicated in patients with severely depressed bone marrow function (see WARNINGS AND PRECAUTIONS sections). IFEX (ifosfamide) is also contraindicated in patients who have demonstrated a previous hypersensitivity to it.
Last reviewed on RxList: 5/12/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Ifex Information
Ifex - User Reviews
Ifex User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.